BHC R&D to Revenue
Bausch Health Companies Inc. Common Stock · R&D to Revenue
BHC R&D to Revenue
Latest reported6.07%period ending
BHC Quarterly R&D/Revenue (0.00% → 6.07%)
Latest values, visible window
High-resolution chart · PNG
BHC r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 6.0659% | |
| 6.458% | |
| 1.824% | |
| 9.213% | |
| 6.2846% | |
| 6.3302% | |
| 6.3697% | |
| 6.4143% | |
| 6.6167% | |
| 7.0135% | |
| 6.3123% | |
| 6.8365% | |
| 7.1989% | |
| 7.356% | |
| 6.4751% | |
| 6.5005% | |
| 6.5074% | |
| 6.6215% | |
| 5.5556% | |
| 5.7319% | |
| 5.5238% | |
| 5.6241% | |
| 5.9648% | |
| 5.3789% | |
| 6.9111% | |
| 6.1133% | |
| 6.7446% | |
| 5.6134% | |
| 5.7621% | |
| 5.8532% | |
| 5.7049% | |
| 5.0094% | |
| 4.4173% | |
| 4.6617% | |
| 4.1609% | |
| 3.6503% | |
| 4.2544% | |
| 4.7416% | |
| 3.8702% | |
| 5.3247% | |
| 5.2066% | |
| 4.3845% | |
| 7.3201% | |
| 3.6458% | |
| 2.9681% | |
| 2.5713% | |
| 2.6664% | |
| 2.8742% | |
| 3.6696% | |
| 3.8861% | |
| 2.6656% | |
| 11.2214% | |
| 2.236% | |
| 2.2276% | |
| 2.1917% | |
| 18.6023% | |
| 2.7167% | |
| 2.5705% | |
| 17.7175% | |
| 2.9098% | |
| 2.9151% | |
| 2.7733% | |
| 7.6012% | |
| 6.8652% | |
| 15.6041% | |
| 30.4537% | |
| 15.9143% | |
| 10.9174% | |
| 23.0925% | |
| 8.3822% | |
| 8.8625% | |
| 10.3087% | |
| 11.6924% | |
| 17.4256% | |
| 14.3573% | |
| 15.889% | |
| 13.73% | |
| 12.2392% | |
| 9.231% | |
| 9.334% | |
| 7.2791% | |
| 10.125% | |
| 9.3003% | |
| 7.7165% | |
| 10.466% | |
| 11.6894% | |
| 7.5684% | |
| 8.1808% | |
| 7.6728% | |
| 9.6401% | |
| 13.0888% | |
| 9.5711% | |
| 10.039% | |
| 9.408% | |
| 5.2799% | |
| 7% | |
| 7.8069% | |
| 6.7425% | |
| 7.9364% | |
| 7.8967% |